Public Health
Regulatory frameworks, surveillance, and interventions aimed at protecting and improving the health of populations, covering disease outbreak response, vaccination programmes, and health promotion.
Foresight tracks Public Health developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.
Current activity
Intensifying
181% above the prior 8-week baseline
3-month trend
Latest alerts below
Last updated
10 April 2026, 15:48
Latest Public Health alerts
The most recent regulatory and guidance signals tracked by Foresight
EU Council Working Party On Civil Protection To Discuss UCPM-HER Draft Amendments (22 April 2026)
The Council of the EU has scheduled a full‑day Working Party on Civil Protection meeting on 22 April 2026 to examine Member States’ draft amendments to the proposed Union Civil Protection Mechanism and Health Emergency Preparedness Regulation. This marks a deeper negotiation phase on EU‑level crisis‑management and health‑emergency governance; authorities and operators should monitor forthcoming compromise texts and ECA Opinion 06/2026 for any changes to funding, coordination, or preparedness‑planning expectations.
Brazil ANVISA Issues IN 433/2026 to Expand Radiopharmaceutical Registrations
ANVISA has issued IN 433/2026, updating Brazil’s radiopharmaceutical lists so 57 diagnostic and therapeutic products can use published clinical literature to demonstrate safety and efficacy under RDC 738/2022, with the instruction taking effect on 06 April 2026. This creates a clearer and potentially faster registration pathway for radiopharmaceutical manufacturers and importers in Brazil, supporting innovation and supply resilience in nuclear medicine while reducing data and time burdens for eligible products.
European Parliament Priority Question Urges Acceleration of PFAS Restriction Proposal
In April 2026 a priority question from MEP Gerben‑Jan Gerbrandy pressed the European Commission to accelerate its PFAS restriction proposal after ECHA and SEAC concluded there is a public health emergency and a broad PFAS ban is necessary.[^1^](https://www.europarl.europa.eu/doceo/document/P-10-2026-001351_EN.html#:~:text=On%2026%20March%202026%2C%20the%20European%20Chemicals%20Agency) If the Commission responds by shortening consultations and limiting exemptions, EU‑wide PFAS bans could arrive sooner than expected, forcing companies to bring forward substitution and supply‑chain transition plans.
Netherlands Proposes Listing Nitazenes Group and Isotonitazepyne Under Opium Act
The Netherlands has proposed a decree to add the nitazenes group of synthetic opioids to list IA of the Opium Act and to schedule the highly potent opioid isotonitazepyne on list I, with an explanatory memorandum now before Parliament (dossier 24077/559). If adopted, this will significantly tighten controls on emerging synthetic opioids, requiring additional Opium Act exemptions and permits for laboratories, healthcare institutions, and other operators handling controlled opioids in the Netherlands.
Texas Commission on Environmental Quality (TCEQ) Approves $1.42 Million in Environmental Penalties Against 88 Entities
On 01 April 2026, the Texas Commission on Environmental Quality approved enforcement orders imposing $1.42 million in penalties on 88 regulated entities for violations of state air, water, waste, and drinking-water rules. This signals sustained enforcement pressure on industrial operators, storage tank owners, municipalities, and public water systems in Texas, reinforcing the need for robust environmental compliance and monitoring.
New York Senate Proposes Private Well Testing Act (S9622)
New York has introduced Senate Bill S9622, the “Private Well Testing Act”, to require testing of private drinking‑water wells at property transfer and expand Department of Health oversight of private supplies. If enacted, sellers and landlords using private wells would face new testing, disclosure and potential treatment obligations, with DOH defining detailed contaminant panels (including PFAS) that could drive significant well‑remediation and data‑reporting work.
European Commission Announces New Global Health Commitments at One Health Summit
In April 2026, the European Commission announced nearly **€800 million** in new global health commitments, combining a €700 million pledge to the Global Fund with targeted One Health, antimicrobial resistance (AMR) and neglected tropical disease investments.[^1^](https://ec.europa.eu/commission/presscorner/detail/en/ip_26_776#:text=The%20European%20Commission%20intends%20to%20pledge%20%E2%82%AC700%20million) These measures reinforce EU leadership on global health security and AMR while signalling the upcoming **Global Health Resilience Initiative**, which will guide future funding priorities and partnerships, particularly with African health systems.[^2^](https://ec.europa.eu/commission/presscorner/detail/en/ip_26_776#:~:text=The%20announcements%20are%20within%20the%20scope%20of%20the%20new%20Global%20Health%20Resilience%20Initiative)
Northern Ireland Amends GP Prescription Rules For Oseltamivir And Zanamivir
Northern Ireland has removed seasonal notification requirements for prescribing influenza antivirals Oseltamivir and Zanamivir, effective May 1, 2026. This shift to year-round prescribing simplifies market access and clinical availability, reducing administrative barriers for pharmaceutical providers and healthcare services.
Brazil Amends CLT To Require Employers To Promote Vaccination And Cancer Prevention Campaigns
Brazil enacted Law No. 15.377/2026 in April 2026, requiring employers to promote vaccination and cancer awareness and inform staff of paid leave rights for preventive screenings. Businesses must update HR protocols and internal communications to ensure compliance with new labour law duties and manage associated leave entitlements.
SPRINT Study Finds Widespread Human And Animal Exposure To Glyphosate And AMPA In Europe And Argentina
A major EU-funded study (April 2026) reveals that human and animal exposure to glyphosate is significantly more widespread than previously estimated through traditional monitoring methods. This evidence of ubiquitous exposure is likely to intensify regulatory scrutiny and could lead to more conservative risk assessments for glyphosate-based products.
New Hampshire Proposes Interim Rule He-P 4040 on Radiation and MRI Machine Registration
New Hampshire is reinstating registration and safety standards for radiation and MRI machines through interim rule He-P 4040, following the expiration of previous regulations. Affected facilities and service providers must verify registration status and shielding compliance to maintain legal operation and avoid penalties during the transition to permanent rules.
Washington State Board of Health Considers Rulemaking on Notifiable Conditions Provisional Reporting (Chapter 246-101 WAC)
Washington is moving to permanently codify provisional reporting requirements for mpox and multidrug-resistant organisms into state health regulations. Healthcare facilities and laboratories should prepare for expanded, permanent electronic reporting obligations and continued alignment with federal antimicrobial threat surveillance.
Washington State Board Of Health Final Agenda Sets Delegated Rulemaking Item On Lead And Copper Rule Improvements (Chapter 246-290 WAC)
Washington state is initiating rulemaking to align state drinking water standards with the 2024 federal Lead and Copper Rule Improvements (LCRI). Regulated entities should anticipate more stringent monitoring, service line inventory mandates, and lower lead action levels as state-level implementation begins.
US FDA Requires ICH E2B(R3) Format for Postmarketing ICSR Submissions From 1 October 2026
The US FDA will mandate the ICH E2B(R3) data standard for all postmarketing individual case safety reports (ICSRs) submitted via ESG NextGen starting October 1, 2026. Manufacturers must upgrade pharmacovigilance systems and data workflows now to ensure seamless transition and avoid submission rejections when the legacy E2B(R2) standard is retired.
California State Water Board Opens Comment Period On Proposed Cross-Connection Control Policy Handbook Revisions
California is set to adopt revisions to its Cross-Connection Control Policy Handbook in April 2026, focusing on accreditation flexibility and streamlined hazard assessments. The update aims to reduce administrative burdens for public water systems and expand the pool of certified specialists without compromising backflow protection standards.
Ireland Moves to Standardise Appearance and Marketing of Nicotine Products Under New Public Health Bill
Ireland has notified the EU of a draft Bill to mandate standardized packaging and strictly limit permitted flavor names for nicotine products by mid-2026. This move aligns vaping regulation with tobacco-style "plain packaging" and marketing bans, requiring immediate reassessment of product design, branding, and retail strategies for the Irish market.
New York Senate Bill S9689 Introduced To Ban Retail Sale Of Flavored Tobacco Products And Accessories
New York has introduced legislation to ban the retail sale of all flavored tobacco products and accessories, including menthol, with a 90-day implementation window post-enactment. This proposal aligns New York with the strictest U.S. state-level tobacco controls, necessitating immediate portfolio assessments and supply chain adjustments for affected businesses.
Chile Starts 2026 Critical Air Episode Management in Curicó and Romeral With Wood Heater Restrictions
Chile has initiated the 2026 Critical Episode Management (GEC) period for Curicó and Romeral, running from April 1 to August 31. Industrial operators must prepare for heightened emissions monitoring, while the expanded ban on wood-fired appliances signals a tightening regulatory environment for traditional heating technologies.
EU Commission Evaluates Tobacco Products and Advertising Directives, Highlighting Gaps for Novel Nicotine Products and Digital Marketing
The European Commission’s April 2026 evaluation of the Tobacco Products and Advertising Directives concludes the current framework is outdated and fails to adequately regulate novel nicotine products and digital marketing. This signals a significant legislative overhaul likely to expand EU regulation to nicotine pouches and herbal products while tightening restrictions on flavors, nicotine limits, and online promotion.
Netherlands Council of State Backs Draft Decree Raising Tobacco Fines and Tightening Distance Sales Ban
The Netherlands is advancing a decree to significantly increase tobacco-related fines and tighten bans on online offerings and retail passages, targeting a July 2026 implementation. Companies must brace for heightened enforcement risks and stricter distribution controls as the government closes loopholes in distance-selling and retail location requirements.
Not a newsletter. Not a feed.
Structured intelligence mapped to your business.
These are just a few of the most recent Public Health alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.
Book a demoFrequently asked questions
Everything you need to know about Foresight's regulatory intelligence platform
Still have questions? Get in touch with our team
Join 3,500+ professionals staying ahead
Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.
Free forever. Unsubscribe anytime.
Read by professionals at